BLFS
NEUTRAL
$24.87
Live
BioLife Solutions, Inc. · NASDAQ
Target $32.44
(+30.5%)
$19.1
52W Range
$29.62
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
65%
BLFS exhibits a weak fundamental health profile with a Piotroski F-Score of 2/9, indicating significant financial distress risks, and lacks an Altman Z-Score for further validation. Despite strong revenue growth of 31.2% and improving earnings surprises in recent quarters, profitability remains negative with negative ROE and ROA. The stock trades at a high valuation with a Forward P/E of 155.44 and Price/Sales of 11.96, above sector averages, while insider selling activity raises caution. Analysts maintain a strong_buy consensus, but this is not yet supported by robust cash flow or consistent earnings generation.
Key Strengths
Strong year-over-year revenue growth of 31.20%, outpacing many peers in the healthcare sector
High gross margin of 64.28%, indicating strong pricing power and cost control in core operations
Exceptional recent earnings surprise performance, averaging +207.14% over the last four quarters
Low debt burden with a Debt/Equity ratio of just 0.06, providing financial flexibility
High liquidity position with a current ratio of 4.66 and quick ratio of 3.31, suggesting solid short-term solvency
Key Risks
Very weak Piotroski F-Score of 2/9, signaling poor financial health and high risk of operational deterioration
Negative profitability across all metrics: profit margin (-3.20%), operating margin (-0.32%), ROE (-5.25%), and ROA (-0.73%)
Lack of Altman Z-Score prevents definitive assessment of bankruptcy risk, but negative earnings and ROE are concerning
Insiders have been consistently selling shares, with $1.28M in sell transactions over the past 6 months and no buys
Valuation multiples are extremely high (Forward P/E: 155.44, Price/Sales: 11.96), making the stock vulnerable to multiple contraction
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BLFS against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BLFS from our newsroom.
Newest → oldest
No matching news yet.